Abstract
Liver toxicity has been one of the major causes for drug attrition. It has caused discontinuation of preclinical and clinical studies, and withdrawals and black box warnings of marketed drugs. Drug-induced hepatotoxicity may lead to organ failure and, ultimately, patient death. Understandably, liver toxicity is one of the most important issues in the drug development cycle. In silico models based on chemical structure provide a cost effective approach for hepatotoxicity, and it can help prioritize lab tests, preclinical and clinical studies. There is no doubt as to the need for predictive methods in every stage of the drug discovery pipeline. However there is a serious shortage of consistent data for the development of reliable models and developing genuinely predictive models for hepatotoxicity remains a challenge.
Current Computer-Aided Drug Design
Title: In Silico Prediction of Hepatotoxicity
Volume: 5 Issue: 2
Author(s): Ailan Cheng
Affiliation:
Abstract: Liver toxicity has been one of the major causes for drug attrition. It has caused discontinuation of preclinical and clinical studies, and withdrawals and black box warnings of marketed drugs. Drug-induced hepatotoxicity may lead to organ failure and, ultimately, patient death. Understandably, liver toxicity is one of the most important issues in the drug development cycle. In silico models based on chemical structure provide a cost effective approach for hepatotoxicity, and it can help prioritize lab tests, preclinical and clinical studies. There is no doubt as to the need for predictive methods in every stage of the drug discovery pipeline. However there is a serious shortage of consistent data for the development of reliable models and developing genuinely predictive models for hepatotoxicity remains a challenge.
Export Options
About this article
Cite this article as:
Cheng Ailan, In Silico Prediction of Hepatotoxicity, Current Computer-Aided Drug Design 2009; 5 (2) . https://dx.doi.org/10.2174/157340909788451883
DOI https://dx.doi.org/10.2174/157340909788451883 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanisms of Hormonal Regulation of Sertoli Cell Development and Proliferation: A Key Process for Spermatogenesis
Current Molecular Pharmacology Hypoglycemic Agents in the Management of Type 2 Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Spontaneous Pneumothorax
Current Respiratory Medicine Reviews Gene-Wide Approach: New Frontiers in Cardiovascular Genetic Epidemiology
Current Hypertension Reviews Tissue Engineering Techniques in Cardiac Repair and Disease Modelling
Current Pharmaceutical Design Thyroid Hormone Ligands and Metabolic Diseases
Current Pharmaceutical Design Radionuclide Imaging in Patients with Ischemic Heart Failure
Current Medical Imaging Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics
CNS & Neurological Disorders - Drug Targets Cardiovascular Consequences of Weightlessness Promote Advances in Clinical and Trauma Care
Current Pharmaceutical Biotechnology PLGA Nanoparticles for Nose to Brain Delivery of Clonazepam: Formulation, Optimization by 32 Factorial Design, In Vitro and In Vivo Evaluation
Current Drug Delivery GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Current Clinical Pharmacology Alert Cell Strategy: Mechanisms of Inflammatory Response and Organ Protection
Current Pharmaceutical Design Preoperative Functional Magnetic Resonance Imaging (fMRI) and Transcranial Magnetic Stimulation (TMS)
Current Medical Imaging Fetal Cardiac Cellular Damage Caused by Anemia in Utero in Hb Bart’s Disease
Current Molecular Medicine Letter to the Editor-in-Chief (Re: Optimal Oxygen Therapy in the Critically Ill Patient)
Current Respiratory Medicine Reviews Vasomotor Effects of Iodinated Contrast Media: Just Side Effects?
Current Vascular Pharmacology HDL Elevation and Lipid Lowering Therapy: Current Scenario and Future Perspectives
Recent Patents on Cardiovascular Drug Discovery Sensory-Motor Integration in the Medial Medulla
Current Neuropharmacology Treating Asthma as a Neuroelectrical Disorder
Inflammation & Allergy - Drug Targets (Discontinued) Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review
Current Medicinal Chemistry